1. Academic Validation
  2. Schisanhenol derivatives and their biological evaluation against tobacco mosaic virus (TMV)

Schisanhenol derivatives and their biological evaluation against tobacco mosaic virus (TMV)

  • Fitoterapia. 2015 Mar;101:117-24. doi: 10.1016/j.fitote.2015.01.006.
Qing-Yao Wang 1 Lu-Lu Deng 2 Jia-Ju Liu 2 Jian-Xin Zhang 2 Xiao-Jiang Hao 2 Shu-Zhen Mu 3
Affiliations

Affiliations

  • 1 College of Pharmacy, Guizhou University, Guiyang 550025, China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550002, China.
  • 2 The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550002, China.
  • 3 The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550002, China. Electronic address: [email protected].
Abstract

Schisanhenol (Sol) was isolated from Schisandra rubriflora, and a series of derivatives (1-16, 15a-16a, and 15b-16b) were designed and prepared by chemical modification. The curative and protective effects of these dibenzocyclooctadiene lignan analogues against tobacco mosaic virus (TMV) were evaluated. Most analogues exhibited stronger protective effects than the positive control ningnanmycin. Dibromoschisanhenol (6) at 0.25mM exhibited the strongest protective activity (83.5±1.8% at 0.25mM), and 14-(3, 5-dibenzyloxy)-benzoyloxyschisanhenol (16) showed a significant curative effect (78.0±3.8% at 0.15mM) that was much stronger than that of the commercial virucide ningnanmycin. This study is the first to demonstrate that natural dibenzocyclooctadiene Lignans and analogues are active against plant viruses.

Keywords

Antiviral activity; Curative effect; Protective effect; Schisanhenol; Schisanhenol derivatives; Tobacco mosaic virus (TMV).

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-N0859
    99.98%, UGT2B7 Inhibitor
    UGT